Will Cannabis Seeds Be Banned?< > analysis

Will Cannabis Genetics Be Banned?

The redefinition of hemp under federal law, scheduled to take effect Nov. 12, spells the end of Farm Bill safeguards for numerous hemp-derived THC items across the country: low-dose beverages as well as THCA bud and delta-8 THC gummies, vapes and other products sold at gas stations and smoke shops.

But the hemp ban also generates a major complication for the legitimate cannabis sector. Seeds from cannabis cultivars that produce flower with more than 0.3% THC are no longer legal to ship out of state.

Although seed buying will probably continue in authorized states, the changes threaten to shutter some seed suppliers and genetics companies, observers say, while causing supply-chain issues for cannabis cultivators and retailers.

"If this language goes through, we will require pop-up shops to sell seeds in every state where it's permitted," Campanella said. "Which is why we're also providing clones and tissue cultivation, because that's not covered in the bill."

When are cannabis seeds and clones illegal to ship across state lines?

The new regulations classify seeds based on the THC capacity of the parent plant. Genetic material such as seeds and clones are rendered illegal if the end product exceeds the threshold.

For now, seeds are still shipping under the 2018 Farm Bill's status quo. But the clock is ticking for businesses like Brothers Grimm and for cannabis cultivators who worry about supply chain disruptions if out-of-state availability to genetics is banned.

Most of the cannabis industry remains largely unaware of the approaching shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.

Without federal intervention in the form of an exception for seeds or a general moratorium, many seed providers will simply be shuttered by November, he added.

"We are operating legally now, but if that shifts, it will upend the legal licensed sector in each state," said Power, whose customers includes seed suppliers as well as licensed business cultivators.

"Consumers are going to forfeit choice, and it will be a significant shutdown for many people."

What are cannabis seed suppliers doing to stay legal after the government hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which tightened cannabis supervision in that state while also limiting hemp-derived THC products to licensed cannabis retailers.

Previously a seed bank, Silberhaze is now focused on the marketing, preservation and IP safeguarding of premium plant genetics.

That's because seed companies hoping to stay compliant in this updated environment must have solid documentation, he said.

"You have to demonstrate where this stuff comes from, so it's extremely important to have documentation, even to the extent where you have breeder names," Silber said.

"Smaller businesses will have to work with improved records and a better chain of custody," he added. "We need that documentation too, because we don't want to be working with shady sources."

To prevent seizures and other legal consequences, seed business owners must "get their ducks in a row" before the new regulations take effect, Silber said.

"Audit all your stuff immediately, and categorize what you can," Silber said. "Take stock, document your lineage, preserve breeder records, and arrange any cannabinoid or terpene information you already have. If regulations change, you'll be in a far better position to understand what may be impacted and make informed decisions."

Does federal marijuana rescheduling impact cannabis genetics?

Silber believes U.S. Drug Enforcement Administration licensing may be required for companies engaged in research.

But for the time being, seed companies can't enroll with the DEA like state-licensed therapeutic cannabis businesses can. Such an option is not available to seed banks, nurseries or genetics companies, said Jim Ickes, https://nativesusa.com/ (https://nativesusa.com/) a lawyer and partner with Frantz Ward's cannabis practice group in Cleveland.

"Genetics activity may be happening inside larger state-licensed therapeutic marijuana businesses, as some states permit dispensaries or registered therapeutic operators to offer seeds, clones or personal growing materials," he said.

"But that is distinct from the DEA creating a freestanding seed supplier registration category."

Some genetics companies are currently changing operational practices to conform with the updated law. According to Ickes, they must address questions including:

• Which of our varieties produce plants above 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don't?
• What does our catalog look like once we organize it against the genetics exclusion?

Ickes also understands confusion from customers who believed government rescheduling of medical marijuana would resolve their situation with financial institutions. However, the recent regulatory wording has moved those conversations beyond the basics of classification, he said.

"Financial institutions ask whether this particular revenue source is legal, whether it ties to state-licensed activity, or whether there's interstate-commerce risk," said Ickes.

"After November, a seed supplier selling high-THC genetics can't address the first question with the hemp classification. It has to point to a lawful state cannabis channel instead. Seed banks dealing in genuine industrial-hemp seed keep the simpler story."

What's the future of cannabis genetics?

Campanella is part of a new coalition of fellow breeders, farmers and researchers that's saying seeds are better defined as farm inputs than controlled substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement work elsewhere.

"How do you regulate something based on what it could become later?" said Campanella. "Our preference is to have that wording removed, or have seeds regulated by the USDA as a hemp product."

But in the interim, Campanella is restructuring Brothers Grimm to operate outside the scope of changing federal oversight. The company plans to keep its Colorado seed facility while placing its Oklahoma tissue cultivation facility as a hedge against federal prohibition of cannabis seeds.

As she noted: "If things evolve in a way where we can't focus on interstate shipping, we'll have other resources to satisfy people's needs without getting ourselves in trouble."